AbbVie

• 2/3/2025

  AbbVie Stock Soars on Blockbuster Earnings and Rosy Outlook

• 1/26/2025

  Johnson & Johnson’s Path to Long-Term Growth Amidst Challenges

• 1/23/2025

  Beyond Big Tech: Why Biotech Stocks Are Poised to Thrive in 2025

• 1/22/2025

  Evolus Soars: Medical Aesthetics Company Beats Expectations with Strong Q4 Report

• 1/3/2025

  Retail Investors Strike Gold: Tech Titans Dominate 2024 Portfolios

• 12/6/2024

  High-Yield Dividend Stocks for Income-Seeking Investors

• 11/24/2024

  AbbVie: A Pharmaceutical Powerhouse Poised for 7-9% Annual Growth

• 11/15/2024

  AbbVie’s Schizophrenia Treatment Fails: What’s Next?

• 11/13/2024

  AbbVie’s Schizophrenia Drug Fails, Bristol Myers Squibb Gains Edge

• 11/13/2024

  Growth & Income: 2 Dividend Kings That Crushed the Market